115 related articles for article (PubMed ID: 11481518)
1. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly Expressed in spindled melanomas.
Iwamoto S; Burrows RC; Agoff SN; Piepkorn M; Bothwell M; Schmidt R
Am J Dermatopathol; 2001 Aug; 23(4):288-94. PubMed ID: 11481518
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic differences between uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Grossniklaus HE; Orcutt J; Kalina RE; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Dec; 120(12):1625-9. PubMed ID: 12470134
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma.
Iwamoto S; Odland PB; Piepkorn M; Bothwell M
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):725-31. PubMed ID: 8912568
[TBL] [Abstract][Full Text] [Related]
5. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation.
Huttenbach Y; Prieto VG; Reed JA
J Cutan Pathol; 2002 Oct; 29(9):562-8. PubMed ID: 12358815
[TBL] [Abstract][Full Text] [Related]
6. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
Trejo O; Reed JA; Prieto VG
J Cutan Pathol; 2002 Aug; 29(7):397-406. PubMed ID: 12139634
[TBL] [Abstract][Full Text] [Related]
7. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
9. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression.
Reed JA; Finnerty B; Albino AP
Am J Pathol; 1999 Aug; 155(2):549-55. PubMed ID: 10433947
[TBL] [Abstract][Full Text] [Related]
10. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
11. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
12. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
13. New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma.
Winnepenninckx V; De Vos R; Stas M; van den Oord JJ
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):319-25. PubMed ID: 14663357
[TBL] [Abstract][Full Text] [Related]
14. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
15. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma with osteoclast-like giant cells: an unusual host response: immunohistochemical and ultrastructural study of three cases and literature review.
Al-Brahim N; Salama S
Am J Dermatopathol; 2005 Apr; 27(2):126-9. PubMed ID: 15798437
[TBL] [Abstract][Full Text] [Related]
18. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
19. Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells.
Walch ET; Albino AP; Marchetti D
Int J Cancer; 1999 Jul; 82(1):112-20. PubMed ID: 10360829
[TBL] [Abstract][Full Text] [Related]
20. Low-affinity nerve growth factor receptor (P75 NGFR) as a marker of perineural invasion in malignant melanomas.
Chan MM; Tahan SR
J Cutan Pathol; 2010 Mar; 37(3):336-43. PubMed ID: 19615036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
